Mikhail Blagosklonny Proves Vital as the Human Race Gradually Wins the War against Cancer and Related Diseases

The war against cancer, aging and other related diseases must be won. While there is still much to do to finally obliterate cancer from our society, it is encouraging to know that there is progress in the positive direction. Gradually we are snuffing the life out of cancer. Many healthcare professionals deserve some accolades for the progress made so far. Top on the list of these distinguished fellows is Mikhail Blagosklonny.

Mikhail Blagosklonny was groomed for this war. He started equipping himself as far back as when he was at First Pavlov State Medical University of St. Petersburg where he obtained his MD in Internal Medicine and PhD in Experimental Medicine and Cardiology. View Mikhail’s profile in LinkedIn

He was selective when the time came to put to work the knowledge acquired in the University. People close to him were not surprise by this because they have always known him to have a strong taste for excellence. He got his choice of working experience in some of the best medical institutions that specialize on cases of cancer, aging and some other related ailments. His wealth of knowledge in the treatment of cancer and aging skyrocketed in no time, why not? At institutions like New York Medical College, Ordway Research Institute and Roswell Park Cancer Institute you have the rare opportunity of meeting with and robbing minds with some of the best brains in the medical profession. Cancer cases that other medical institutions could not proffer solutions to are referred to these places. Mikhail Blagosklonny profited massively having spent quite a while in these three institutions. In fact, he is currently professor of Oncology with Roswell Park Cancer Institute.

He was bent on finding more effective ways of treating cancer and retarding the aging process so that people can live long enough to enjoy what they have spent all their lives laboring for. The international society stood up in appreciation of his theory on the likely action of the TOR signaling, which has been very useful in treating cancer and aging. Mikhail after several researches came up to vehemently support the use of rapamycin for cancer and aging as he discovered the drug has the capacity to slow down the aging process since it retards the growth of tumor.

Winning the war against cancer, aging and other related ailments would be accomplished sooner than expected if the world could keep producing, at least, a Mikhail Blagosklonny every two decades. Follow Mikhail on Loop

Mikhail Blagosklonny’s Flourishing Medical Career

Mikhail Blagosklonny is a renowned oncologist based in New York. He also does extensive research on aging and how to prevent and treat age-related illnesses. He holds a masters’ degree and a PhD in medicine from the First Pavlov State Medical University of St. Peterburg.

According to Impact Journals, Mikhail Blagosklonny began his career in the medical profession in 2002 when he was appointed to the New York Medical College as professor of medicine. Soon after, he joined the Ordway Research Institute where he worked for 7 years, taking on various tasks and research topics in his position as senior scientist. He therefore gained invaluable experience in the medical profession while working there.

His Research and Findings

His LinkedIn profile shows that Mikhail Blagosklonny’s experience and expertise in the field led to his appointment as professor of oncology at the Roswell Park Cancer Institute in 2009.

Mikhail Blagosklonny has proven to be a very valuable asset to the Roswell Park Cancer Institute.  He also tries to find the relation between cancer and aging and believes that by tackling age-related illnesses, the treatment and prevention of cancer will be made easier.

For instance, from his research and findings, Mikhail came up with a hypothesis about aging and cancer. He proposed the use of rapamycin, a drug used in the treatment of cancer, as a drug for slowing down the aging process.

Bottom Line

The impact of Mikhail Blagosklonny’s work is being felt all through the world as his findings have helped a great deal in developing more advanced cancer treatments that do not affect the normal cells in the body. He is the editor-in-chief of Oncotarget and Cell Cycle, and associate editor of Cancer Research and Autophagy among other publications.

Besides his role as editor of these various publications, he has also published several research articles and papers which are used by various institutions to teach medical students. Mikhail Blagosklonny is very passionate about his work and will stop at nothing to ensure he achieves his goals.